BTCA — Bactolac Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesMid Cap

Annual balance sheet for Bactolac Pharmaceutical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2001 September 30th	2002 September 30th	2003 September 30th	2004 September 30th	2005 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10KSB	10-K	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.782	0.793	1.07	1.79	0.678
Net Total Accounts Receivable
Net Total Receivables	4.13	4.28	4.21	2.94	3.58
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6.92	7.46	7.87	8.14	8.21
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.73	9.28	4.6	1.12	1.44
Net Goodwill
Long Term Notes Receivable
Other Long Term Assets
Total Assets	25.7	24.5	20.5	17.5	19.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.61	6.21	2.98	2.16	3.63
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	8.77	8.61	8.39	2.35	6.33
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.9	15.9	12.1	15.2	12.8
Total Liabilities & Shareholders' Equity	25.7	24.5	20.5	17.5	19.2
Total Common Shares Outstanding